Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of the Feasibility and Efficacy of Breast Conserving Surgery in Patients With MRI Detected Multi-Centric Breast Cancer

NCT01100489 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT01100489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01100489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of the Feasibility and Efficacy of Breast Conserving Surgery in Patients With MRI Detected Multi-Centric Breast Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 2
Overall status
Withdrawn
Start date
February 28, 2010
Completion date
October 31, 2011
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, estrogen receptor-negative breast cancer, estrogen receptor-positive breast cancer, her2-negative breast cancer, her2-positive breast cancer, invasive ductal breast carcinoma, invasive lobular breast carcinoma, male breast cancer, medullary ductal breast carcinoma with lymphocytic infiltrate, mucinous ductal breast carcinoma, papillary ductal breast carcinoma, progesterone receptor-negative breast cancer, progesterone receptor-positive breast cancer, stage i breast cancer, stage ii breast cancer, tubular ductal breast carcinoma